Tenderwize
Zurück zur Suche

Non-exclusive discount agreement for Midazolam (ATC N05CD08) in Lower Saxony

AOK Niedersachsen. Die Gesundheitskasse.·Hannover, Germany·Deadline Apr 27, 2028 · 611 days left·Open·Supplies·Framework
Structured notice only
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V für die im Rahmen des Sprechstundenbedarfs in Niedersachsen verordnungs- und abgabefähigen Arzneimittel mit dem Wirkstoff Midazolam (ATC-Code (WHO): N05CD08).

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Warum diese Bewertung?

Chance

50 / 100

Komplexität

20 / 100

Risikofaktoren

No estimated contract value or maximum framework value is available, making it difficult to assess revenue potential.

The notice states it is not a public procurement; legal challenges must be brought before social courts, not procuremen...

No procurement documents available

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jun 2028
  • Supply of Midazolam (ATC N05CD08) as pharmaceutical products under a non-exclusive discount agreement for outpatient care in Lower Saxony, Germany.
  • Participation is open to all pharmaceutical entrepreneurs meeting eligibility criteria on a first-come, first-served basis without competitive selection.
Vollständige Zusammenfassung anzeigen

This is a non-exclusive discount agreement (open-house model) for Midazolam (ATC N05CD08) as pharmaceutical products for outpatient care in Lower Saxony, Germany, from 01.07.2026 to 30.06.2028. All eligible pharmaceutical entrepreneurs can join at any time (monthly) during the period. No selection is made; the notice is published for transparency. No estimated value is provided.

Risiken

No estimated contract value or maximum framework value is available, making it difficult to assess revenue potential.

The notice states it is not a public procurement; legal challenges must be brought before social courts, not procuremen...

No procurement documents available

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Must be a pharmaceutical entrepreneur as defined in § 4 Abs. 18 AMG with respect to the offered medicinal products containing Midazolam.
  • Must have a seat in Germany, another EU member state, or an EEA state (§ 9 Abs. 2 Satz 1 AMG).
  • Local representatives are allowed only if they themselves are pharmaceutical entrepreneurs for the offered products.

Anforderungen können unvollständig sein.

Auftraggeber

Lose (1)

LOT-0000

Non-exclusive discount agreement for Midazolam (ATC N05CD08) in Lower Saxony

Conclusion of a non-exclusive discount agreement according to § 130a Abs. 8 SGB V for the active ingredient Midazolam (ATC code: N05CD08) for outpatient care in Lower Saxony. Open-house model: no selection, all eligible pharmaceutical entrepreneurs can join. Contract duration: 01.07.2026 to 30.06.2028, with possible monthly joining and 6-week notice termination.

SuppliesFrameworkEU fundedElectronic submission

Ort

DE929, Germany

Dauer

Jun 2026 - Jun 2028

Kategorie

Pharmaceutical products

Frist

Deadline Apr 27, 2028

Vergabedetails

Veröffentlichungsdatum
14 May 2026
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
332947-2026

Ähnliche Ausschreibungen